Wes Brazell

Chief Financial Officer
ophthalmology
TearLab Corporation
United States of America

Business Expert Ophthalmology
Biography

Mr. Wes Brazell has been the Chief Financial Officer of TearLab Corporation since July 6, 2015. Mr. Brazell has an accomplished history of financial leadership success. In an executive management career that spans close to three decades, he served as the Chief Financial Officer of Academic Partnerships, a leader in partnering with universities to increase access to and affordability of higher education through technology and online instruction. Previously, his 21 years of progressive experience at Alcon Laboratories, Inc. included executive roles as Vice President, Global Business Planning and Analysis, Chief Financial Officer (Europe, Middle East and Africa Region) and Chief Financial Officer (United States Region), in addition to earlier positions in commercial finance, internal audit and investor relations. Mr. Brazell was an Attorney-in-Fact at Alcon Inc. Before joining Alcon in 1993, he held various positions at KPMG Peat Marwick, including serving audit clients in the healthcare, manufacturing and financial sectors as well as training staff accountants in auditing, reporting and leadership. Mr. Brazell is a Certified Public Accountant, holds a Bachelor of Business Administration degree in Accounting from Baylor University and has completed executive leadership training at Harvard Business School. Mr. Wes Brazell has been the Chief Financial Officer of TearLab Corporation since July 6, 2015. Mr. Brazell has an accomplished history of financial leadership success. In an executive management career that spans close to three decades, he served as the Chief Financial Officer of Academic Partnerships, a leader in partnering with universities to increase access to and affordability of higher education through technology and online instruction. Previously, his 21 years of progressive experience at Alcon Laboratories, Inc. included executive roles as Vice President, Global Business Planning and Analysis, Chief Financial Officer (Europe, Middle East and Africa Region) and Chief Financial Officer (United States Region), in addition to earlier positions in commercial finance, internal audit and investor relations. Mr. Brazell was an Attorney-in-Fact at Alcon Inc. Before joining Alcon in 1993, he held various positions at KPMG Peat Marwick, including serving audit clients in the healthcare, manufacturing and financial sectors as well as training staff accountants in auditing, reporting and leadership. Mr. Brazell is a Certified Public Accountant, holds a Bachelor of Business Administration degree in Accounting from Baylor University and has completed executive leadership training at Harvard Business School.

Research Intrest

Ophthalmic Pathology